Partnering is increasingly the choice for securing market share and business growth...
... Teva’s recent acquisition of Barr Pharmaceuticals may be the latest headline grabbing deal, but industry and commerce alike must have a complete understanding of the medium-sized generic drug manufacturers. The operating environment is changing rapidly as the industry matures and growth focuses on new market opportunities.
Consolidation continues to affect the market, with fewer big players dominating. Acquisition is still a favoured route to fast market access but strategic partnering is on the rise. In such a market you need to know... But…
- Who are the medium-sized companies of note? - How well do they perform? - What drugs do they produce? - Where are they located?
